Cairo University
Cairo, Egypt
NCT Number: NCT02843698
The study aims to investigate the effect of dexmedetomidine on oxygenation and lung mechanics in morbidly obese patients
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 4
Cairo, Egypt
The patients of interest are morbid obese patients scheduled for bariatric surgery. Dexmeditomidine will be infused intraoperatively after induction of anesthesia. lung mechanics (dead space and compliance) as well as oxygenation (PF ratio) will be monitored intraoperatively and postoperatively
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Dexmedetomidine infusion was previously reported to improve oxygenation and lung dynamics in patients with obstructive lung diseases. In our study we are going to investigate its effect on oxygenation and lung dynamics in restrictive lung disease
Other names: Precedex
Normal saline
Other names: Saline
Time frame: 2 hours
assessed by P/F ratio
Time frame: 2 hours
lung compliance and dead space
Time frame: 2 hours
arterial blood pressure measured in mmHg
Time frame: 2 hours
plateau airway pressure measured in cmH2o
Time frame: 2 hours
number of heart beats per minute
Cairo University
Other
Effects of Dexmedetomidine on Oxygenation and Lung Mechanics in Morbidly Obese Patients Undergoing Bariatric Operations: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05119491
Restrictive Lung Disease
Zagazig, Egypt
View Trial DetailsNCT04668599
Cardiomyopathies, Cardiovascular Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT03506906
Apnea, Chronic Disease
Solingen, North Rhine-Westphalia, Germany
View Trial DetailsNCT01601288
Cough, Dyspnea
Singapore
View Trial Details